AGN 2.70% 76.0¢ argenica therapeutics limited

Ann: Sentinel Subjects Dosed in Second Cohort of Phase 1 Trial, page-6

  1. 9,854 Posts.
    lightbulb Created with Sketch. 980
    Yes. By my calculations going by the first cohort results we should be getting the 2nd cohort safety results tomorrow. Or thereabouts anyway.
 
watchlist Created with Sketch. Add AGN (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.